Compare Listings

$11,500,000$450,000/EBITDA

This company has been in the Colombian market for 19 years, it owns the approved INVIMA registrations. There is a serious conversations to expand market to Guatemala and 5 more countries in Central America with one big distribu ...

$11,500,000$450,000/EBITDA
$450,000

Manufacturing, Pharma

property

20-Year Old Pharmaceutical South American Brand

EBITDA

$450,000

Gross

$2,000,000

Price

$11,500,000

Colombia For Sale

This company has been in the Colombian market for 19 years, it owns the approved INVIMA registrations.

There is a serious conversations to expand market to Guatemala and 5 more countries in Central America with one big distributor. There are 289 affiliated pharmacies in all main cities of Colombia and in many secondary cities. The CRM is very well organized, with 1397 members between doctors, pharmacies and the institutional market. There are 289 affiliated pharmacies in all main cities of Colombia and in many secondary cities.

Commercial Market

  • 75% of sales are through doctors
  • 25% of sales are Institutional

The company buys the API, the excipients, the packaging and the products, and everything is made by outsourcing in specialized plants in Colombia that are approved by the INVIMA.

Currently, there are 32 products registered and approved by the INVIMA and the Superintendence of Industry and Commerce. Two new products are about to be approved by the INVIMA.

An approval by the INVIMA in Colombia takes an average of 2 years and USD $30.000 of investment to achieve.

This business has 5 nutritional products, of which we own the brand, but not the registry.

Products

o Antibiotics
o Analgesics
o Anti-inflammatory
o Antihistamines
o Cardiovascular
o Nutritional
o Gastroenterology
o Lipid lowering drugs
o Pediatric Products: Antibiotics and Nutritional.

MergersCorp M&A
International As Seen On

  • brand 1
  • brand 1
  • brand 1
  • brand 1
  • brand 1
Skype